Obesity cost-effectiveness of therapy: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
 
(One intermediate revision by one other user not shown)
Line 14: Line 14:


==References==
==References==
{{reflist|2}}
 
{{Reflist|2}}
 
{{WH}}
{{WH}}
{{WS}}
{{WS}}
[[Category:Metabolic disorders]]
 
[[Category:Health risks]]
[[Category:Primary Care]]
[[Category:Nutrition]]
[[Category:Overview complete]]
[[Category:Gastroenterology]]
[[Category:Gastroenterology]]
[[Category:Cardiology]]
[[Category:Cardiology]]
[[Category:Endocrinology]]
[[Category:Endocrinology]]
[[Category:Needs overview]]

Latest revision as of 13:40, 12 July 2016

Obesity Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Obesity from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

Chest X Ray

CT

MRI

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Lifestyle Intervention and Counseling (Comprehensive Lifestyle Intervention)

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

USPSTF Recommendations and Guidelines on Management of Obesity

2017 Guidelines for Screening of Obesity in Children and Adolescents

2012 Guidelines for Screening of Obesity in Adults

AHA/ACC/TOS Guidelines on Management of Overweight and Obesity

2013 AHA/ACC/TOS Guidelines on Management of Overweight and Obesity

Obesity cost-effectiveness of therapy On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Obesity cost-effectiveness of therapy

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Obesity cost-effectiveness of therapy

CDC on Obesity cost-effectiveness of therapy

Obesity cost-effectiveness of therapy in the news

Blogs on Obesity cost-effectiveness of therapy

Directions to Hospitals Treating Obesity

Risk calculators and risk factors for Obesity cost-effectiveness of therapy

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Cost-Effectiveness of Therapy

Implications of the present world trend in obesity are:

  • Increased pressure on airline revenues (or increased fares) due to lobbying efforts to increase seating width on commercial airplanes, and due to higher fuel costs: in 2000, extra weight of obese passengers cost airlines and consumers US$275,000,000.[1]
  • Increased litigation by obese persons suing restaurants (for causing obesity)[2] and airlines (over airline seating width)[2] [3]. The Personal Responsibility in Food Consumption Act of 2005 was motivated by a need to reduce litigation from obesity activists.
  • Sizable societal economic costs attributable to obesity, with medical costs attributable to obesity rising to 78.5 billion dollars or 9.1 percent of all medical expenditures in the U.S. as of 1998[3][4]
  • Decreased worker productivity as measured by usage of disability leave and absenteeism at work.[5]
  • A study examining Duke University employees found that those with a BMI>40 filed twice as many workers compensation claims as workers whose BMI was 18.5-24.9, and had more than 12 times as many lost work days. The most common injuries were due to falls and lifting, and affected the lower extremities, wrists or hands, and backs.[6]

References

  1. Dannenberg AL, Burton DC, Jackson RJ (2004). "Economic and environmental costs of obesity: the impact on airlines". American journal of preventive medicine. 27 (3): 264. doi:10.1016/j.amepre.2004.06.004. PMID 15450642.
  2. 109th U.S. Congress (2005-2006) H.R. 554: 109th U.S. Congress (2005-2006) H.R. 554: Personal Responsibility in Food Consumption Act of 2005
  3. Finkelstein EA, Fiebelkorn IA, Wang G (2003). "National medical spending attributable to overweight and obesity: how much, and who's paying". National medical spending attributable to overweight and obesity: how much, and who's paying. Online (May).
  4. "Obesity and Overweight: Economic Consequences". CDC. Retrieved 2007-09-05. Unknown parameter |pubdate= ignored (help)
  5. The Economic Costs of Physical Inactivity, Obesity, and Overweight in California Adults, report by Chenoweth & Associates Inc. for the Cancer Prevention and Nutrition Section, California Center for Physical Activity, California Department of Health Services, Sacramento, CA, 2005.
  6. Ostbye T, Dement JM, Krause KM (2007). "Obesity and workers' compensation: results from the Duke Health and Safety Surveillance System". Arch. Intern. Med. 167 (8): 766–73. doi:10.1001/archinte.167.8.766. PMID 17452538.

Template:WH Template:WS